Session Details

P002 Annual Business Meeting and Plenary

Sun, Mar 9, 9:00 AM - 12:00 PM
Chapin Theater - Level III
2.25 CME Available Plenary
View Map

DESCRIPTION

Open admission, no tuition or ticket

During the Annual Business Meeting, hear from the AAD/A’s president Seemal R. Desai, MD, FAAD, Secretary-Treasurer Daniel Bennett, MD, FAAD and Executive Director & CEO Elizabeth K. Usher, MBA about the AAD/As state of affairs.

INFORMAL DISCUSSION OF ISSUES OF IMPORTANCE FROM THE FLOOR*
Pursuant to the Administrative Regulation of the American Academy of Dermatology and the American Academy of Dermatology Association, during any debate at a membership meeting each speaker must introduce themselves by name and professional position. He or she must also identify any potential conflicts of interest. *No CME Credit.

The plenary session offers attendees the opportunity to hear from renowned experts on topics that impact dermatologists today. Speakers include Academy leadership and award-winning named lecturers.

LEARNING OBJECTIVES

1.

Discuss remarkable changes in health care concerns and changes in educational delivery tools.

SCHEDULE

1:00 PM

Annual Business Meeting

Seemal R. Desai, MD, FAAD

1:45 PM

Chair's Welcome

Kathryn Schwarzenberger, MD, FAAD

1:50 PM

Clarence S. Livingood, MD Memorial Award and Lectureship: Numbers and the Narrative: Leadership and Advocacy with Stories and Data

Marta Jane Van Beek, MD, MPH, FAAD

2:15 PM

President's Address

Seemal R. Desai, MD, FAAD

2:30 PM

Lila and Murray Gruber Memorial Cancer Research Award and Lectureship: From Cell Atlases to Medicines with AI

Aviv Regev, PhD, MSc

2:55 PM

President-Elect Address

Susan C. Taylor, MD, FAAD

3:10 PM

Marion B. Sulzberger, MD Memorial Award and Lectureship: Patients don't read the textbooks, they write them: insights from patient-driven investigation

Rachael Clark, MD, PhD, FAAD

3:35 PM

John Kenney Jr., MD Lifetime Achievement Award and Lectureship: Vitiligo: A 45 Year Journey of Science and Service

Pearl E. Grimes, MD, FAAD

SPEAKERS

Daniel D Bennett, MD, FAAD

Daniel D Bennett, MD, FAAD

Rachael Clark, MD, PhD, FAAD

Rachael Clark, MD, PhD, FAAD

Seemal R. Desai, MD, FAAD

Seemal R. Desai, MD, FAAD

Pearl E. Grimes, MD, FAAD

Pearl E. Grimes, MD, FAAD

Aviv Regev, PhD, MSc

Aviv Regev, PhD, MSc

Kathryn Schwarzenberger, MD, FAAD

Kathryn Schwarzenberger, MD, FAAD

Susan C. Taylor, MD, FAAD

Susan C. Taylor, MD, FAAD

Marta Jane Van Beek, MD, MPH, FAAD

Marta Jane Van Beek, MD, MPH, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Daniel D Bennett, MD, FAAD

No financial relationships exist with ineligible companies.

Rachael Clark, MD, PhD, FAAD

Almirall – Advisory Board(Honoraria); American Academy for the Advancement of Science – Advisory Board(Fees); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Galderma Research & Development, LLC – Investigator(Grants/Research Funding); Sedec Therapeutics – Advisory Board(Fees);

Seemal R. Desai, MD, FAAD

AbbVie – Consultant(Fees), Speaker(Fees); Allergan, Inc – Consultant(Fees); Amgen – Consultant(Fees); Apogee Therapeutics – Consultant(Fees); Atacama Therapeutics – Investigator(Grants/Research Funding); Avita – Consultant(Fees); Ballature Beauty – Consultant(Fees); Beiersdorf, Inc. – Consultant(Fees); Bristol-Myers Squibb – Consultant(Fees); Candela Corporation – Consultant(Fees); Cassiopea S.p.A. – Consultant(Fees); Castle Biosciences – Consultant(Fees); Cutera, Inc. – Consultant(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees); Ferndale Laboratories, Inc. – Consultant(Honoraria); Foamix – Consultant(Fees); Foundation for Research & Education of Dermatology – Advisory Board(Fees); Galderma Laboratories, LP – Consultant(Fees), Speaker(Honoraria); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Gore Range Capital – Consultant(Stock Options), Stockholder(Stock Options); Hyphens Pharma – Consultant(Fees); Illuminate Skin Care LLC – Founder(Other Financial Benefit); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); International Society of Dermatology – Board of Directors(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Fees); Johnson and Johnson – Consultant(Fees); L'Oreal USA Inc. – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees); Lyceum Health – Consultant(Fees); Medscape – Other(Fees); National Psoriasis Foundation – Other(No Compensation Received); Ortho Dermatologics – Consultant(Fees); PDH Holdings LLC – Other(No Compensation Received); Pfizer Inc. – Consultant(Fees), Speaker(Honoraria); Revision Skincare – Consultant(Fees); Sanofi/Regeneron – Consultant(Fees); Scientis – Consultant(Fees); Skin Science Advisors – Consultant(Fees); SkinMedica, Inc. – Investigator(Grants/Research Funding); UCB – Consultant(Fees); Verrica Pharmaceuticals Inc – Consultant(Fees); VYNE Therapeutics – Consultant(Fees); Womens Derm Society – Board of Directors(No Compensation Received);

Pearl E. Grimes, MD, FAAD

AbbVie – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Grants/Research Funding); Laseroptek USA – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant(Honoraria); Scientis – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Investigator(Grants/Research Funding); Versicolor Technologies – Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Honoraria);

Aviv Regev, PhD, MSc

Celsius Therapeutics – Founder(Stock); Genentech, Inc. – Employee (w-2 relationship)(Salary); Hoffman-La Roche Ltd. – Employee (w-2 relationship)(Stock Options); Immunitas Therapeutics – Stockholder Private Company(Stock);

Kathryn Schwarzenberger, MD, FAAD

Pfizer Inc. – Data Safety Monitoring Board(Fees); Pretel, Inc. – Founder(No Compensation Received);

Susan C. Taylor, MD, FAAD

AbbVie – Advisory Board(Honoraria); Allergan Aesthetics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant(Honoraria); Armis Biopharma, Inc. – Advisory Board(No Compensation Received); Avita Medical – Advisory Board(Honoraria); Beiersdorf, Inc. – Advisory Board(No Compensation Received), Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Biorez, Inc. – Advisory Board(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Consultant(Honoraria); Catalyst Medical Education LLC – Speaker/Faculty Education(Honoraria); CME Outfitters – Speaker/Faculty Education(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Dermsquared – Speaker/Faculty Education(Honoraria); Dior – Consultant(Honoraria); Eli Lilly and Company – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); EPI Health – Advisory Board(Honoraria); Estee Lauder – Advisory Board(Honoraria); Evolus, Inc. – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria); GloGetter, Inc – Advisory Board(No Compensation Received); HMP Global – Speaker/Faculty Education(Honoraria); Hugel – Advisory Board(Honoraria); Incyte – Advisory Board(Honoraria); Johnson & Johnson Innovative Medicine – Advisory Board(No Compensation Received); L'Oreal USA Inc. – Advisory Board(No Compensation Received); LearnSkin – Speaker/Faculty Education(Honoraria); Medscape – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); MJH Life Sciences – Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Piction Health – Advisory Board(No Compensation Received); Sanofi – Consultant(Honoraria); Scientis – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria); VeraDermics Inc. – Advisory Board(No Compensation Received); Vichy Laboratoires – Advisory Board(Honoraria);

Marta Jane Van Beek, MD, MPH, FAAD

No financial relationships exist with ineligible companies.